- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有12家主力机构披露2026-06-30报告期持股数据，持仓量总计2.03亿股，占流通A股49.32%
- 波段诊断：
-
技术面诊股
诊断结果：5.7技术面打败了69%的股票
技术面评分前10的股票
近期的平均成本为9.06元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为9.06元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"9.06","date":1790150803,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，接近行业平均水平。
[{"date":"2026.09.24","stock":"-2.39","trade":"-2.83","ind":"-2.34"},{"date":"2026.09.23","stock":"-2.23","trade":"1.31","ind":"-0.64"},{"date":"2026.09.22","stock":"-0.11","trade":"1.92","ind":"-0.05"},{"date":"2026.09.21","stock":"2.17","trade":"4.64","ind":"0.65"},{"date":"2026.09.18","stock":"3.48","trade":"2.61","ind":"1.72"},{"date":"2026.09.17","stock":"3.24","trade":"1.50","ind":"-0.33"},{"date":"2026.09.16","stock":"0.94","trade":"0.82","ind":"1.26"},{"date":"2026.09.15","stock":"-0.81","trade":"-1.62","ind":"-0.72"},{"date":"2026.09.14","stock":"1.65","trade":"2.96","ind":"-0.64"},{"date":"2026.09.11","stock":"-0.82","trade":"-2.86","ind":"-1.08"},{"date":"2026.09.10","stock":"-2.17","trade":"-2.43","ind":"-0.77"},{"date":"2026.09.09","stock":"-2.02","trade":"-1.46","ind":"0.15"},{"date":"2026.09.08","stock":"1.36","trade":"1.93","ind":"-0.52"},{"date":"2026.09.07","stock":"0.57","trade":"0.09","ind":"1.91"},{"date":"2026.09.04","stock":"-0.57","trade":"-0.93","ind":"-0.79"},{"date":"2026.09.03","stock":"-0.90","trade":"0.47","ind":"0.10"},{"date":"2026.09.02","stock":"-2.95","trade":"-1.26","ind":"-1.88"},{"date":"2026.09.01","stock":"2.46","trade":"0.61","ind":"-1.02"},{"date":"2026.08.31","stock":"-1.87","trade":"-2.01","ind":"0.44"},{"date":"2026.08.28","stock":"-2.36","trade":"-2.41","ind":"-0.68"},{"date":"2026.08.27","stock":"1.75","trade":"0.32","ind":"1.50"}]
双成药业,深证成指,生物制品指数
压力支撑
该股压力位为9.08元，支撑位为8.90元。
[{"text":"\u538b\u529b\u4f4d","value":"9.08","date":1790179200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"8.90","date":1790179200,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.5资金面打败了10%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体无进出。
更新时间：09月25日 12:30
| 机构今日流向(万元) | -3197.04 | 机构5日流向(万元) | 904.69 |
| 机构10日流向(万元) | -1861.66 | 机构20日流向(万元) | -16657.66 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少53.48万股，其中基金数没有增加，主力净增仓9家，暂未发现中长期投资价值。
截止2026-06-30，共12家主力机构（基金9家，一般法人3家），持仓量总计20268.11万股，占流通A股49.32%
其中，基金持仓与2025-12-31相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：10家 ，持有156.52万股
从主力名单中消失：1家 ，原持有210万股
其中，基金持仓与2025-12-31相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：10家 ，持有156.52万股
从主力名单中消失：1家 ，原持有210万股
消息面诊股
诊断结果：5.9消息面打败了20%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 【涨停直击】医药板块走强，瑞康医药直线涨停
2026-09-18 - 近期国产药在海外密集获批上市，涉及华海药业、普洛药
2026-09-17 - 近期大批国产药拿下海外上市许可，覆盖欧美与中亚等市
2026-09-15 - 海外业务再放量，双成药业一产品在新西兰获批上市
2026-09-14 - 双成药业：控股股东更名及经营范围变更完成
2026-09-14 - 双成药业：精氨加压素注射液在新西兰获批上市 积极拓
2026-09-11 - 政策东风与产业升级交汇，双成药业站在医药价值重估的
2026-08-31 - 从1.31%到80.77%，海外营收占比飙升！双成
2026-08-25 - 告别ST困境，出海全球化提速，双成药业价值重估在即
2026-08-24 - 股东追踪|韩东等新进双成药业前十大流通股东
2026-08-22
消息列表
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-22 |
| 利好 | 业绩预告 | 预计扭亏 | 2026-07-15 |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-06-27 |
| 利好 | 上市变动 | 公司摘帽 | 2026-05-25 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-04-18 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-09 |
| 利好 | 业绩预告 | 预计扭亏 | 2026-01-27 |
| 一般消息 | 高管变动 | 不再担任 | 2026-01-08 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：8.2行业面打败了99%的股票
生物制品行业最新资金流向
近10日来该行业走势明显向上，明显跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势明显向上，明显跑赢大盘。
[{"date":"2026.09.24","price":"-2.34","value":"-2.83"},{"date":"2026.09.23","price":"-0.64","value":"1.31"},{"date":"2026.09.22","price":"-0.05","value":"1.92"},{"date":"2026.09.21","price":"0.65","value":"4.64"},{"date":"2026.09.18","price":"1.72","value":"2.61"},{"date":"2026.09.17","price":"-0.33","value":"1.50"},{"date":"2026.09.16","price":"1.26","value":"0.82"},{"date":"2026.09.15","price":"-0.72","value":"-1.62"},{"date":"2026.09.14","price":"-0.64","value":"2.96"},{"date":"2026.09.11","price":"-1.08","value":"-2.86"},{"date":"2026.09.10","price":"-0.77","value":"-2.43"},{"date":"2026.09.09","price":"0.15","value":"-1.46"},{"date":"2026.09.08","price":"-0.52","value":"1.93"},{"date":"2026.09.07","price":"1.91","value":"0.09"},{"date":"2026.09.04","price":"-0.79","value":"-0.93"},{"date":"2026.09.03","price":"0.10","value":"0.47"},{"date":"2026.09.02","price":"-1.88","value":"-1.26"},{"date":"2026.09.01","price":"-1.02","value":"0.61"},{"date":"2026.08.31","price":"0.44","value":"-2.01"},{"date":"2026.08.28","price":"-0.68","value":"-2.41"},{"date":"2026.08.27","price":"1.50","value":"0.32"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 近岸蛋白 | 51.54% | 25.56% | 5.7分 |
| 2 | 百普赛斯 | 41.03% | 22.29% | 6.2分 |
| 3 | 义翘神州 | 40.00% | 37.05% | 5.8分 |
| 4 | 诺唯赞 | 20.17% | 25.69% | 6.9分 |
| 5 | 昊帆生物 | 13.47% | 13.64% | 6.5分 |
| 6 | 百奥泰 | 11.15% | 24.43% | 6.2分 |
| 8 | 金迪克 | 9.57% | 6.06% | 5.5分 |
| 10 | 欧林生物 | 7.03% | 17.92% | 6.6分 |
| 12 | 禾元生物 | 5.26% | 14.35% | 6.7分 |
| 14 | 诺诚健华 | 3.39% | 3.64% | 6.1分 |
| 16 | 甘李药业 | 2.89% | 6.22% | 6.5分 |
| 18 | 泰诺麦博 | 1.39% | 19.27% | 5.6分 |
| 20 | 百克生物 | 0.57% | 16.32% | 6.2分 |
| 22 | 康华生物 | -0.58% | 9.21% | 6.0分 |
| 24 | 艾迪药业 | -1.05% | 4.66% | 5.8分 |
| 26 | 君实生物 | -1.94% | 6.60% | 6.3分 |
| 28 | 神州细胞 | -3.06% | 8.37% | 5.9分 |
| 30 | 博雅生物 | -3.22% | 2.48% | 5.4分 |
| 32 | 西藏药业 | -3.85% | 1.98% | 5.8分 |
| 34 | 荣昌生物 | -4.49% | 1.88% | 6.5分 |
| 36 | 康泰生物 | -4.94% | 9.43% | 5.9分 |
| 38 | 通化东宝 | -5.27% | -1.15% | 5.3分 |
| 40 | 康辰药业 | -6.67% | 2.91% | 6.1分 |
| 42 | 四环生物 | -7.09% | -3.67% | 4.9分 |
| 44 | 长春高新 | -8.03% | -2.05% | 5.2分 |
| 46 | - | -8.59% | 3.02% | 分 |
| 48 | - | -9.09% | 4.72% | 分 |
| 50 | 迈威生物 | -10.97% | 2.88% | 5.4分 |
| 52 | 沃森生物 | -12.84% | 3.90% | 5.9分 |
| 54 | 智飞生物 | -13.27% | 5.34% | 5.5分 |
| 56 | 信诺维 | - | 14.41% | 4.4分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-06-30 ]公司经营
盈利能力：很强，居行业前列，两项指标的行业排名分别为 16/73 ， 33/73。
[{"date":"2026-06-30","value":"3.25","vol":"-8.07"},{"date":"2026-03-31","value":"0.83","vol":"-6.34"},{"date":"2025-12-31","value":"4.73","vol":"-12.02"},{"date":"2025-09-30","value":"-0.64","vol":"-9.89"},{"date":"2025-06-30","value":"-4.81","vol":"-3.57"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
3.25 | 0.83 | 4.73 | -0.64 | -4.81 |
| 行业(%) | -8.07 | -6.34 | -12.02 | -9.89 | -3.57 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"55.61","vol":"55.74"},{"date":"2026-03-31","value":"62.35","vol":"60.27"},{"date":"2025-12-31","value":"54.75","vol":"65.27"},{"date":"2025-09-30","value":"56.71","vol":"66.41"},{"date":"2025-06-30","value":"46.72","vol":"66.14"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
55.61 | 62.35 | 54.75 | 56.71 | 46.72 |
| 行业(%) | 55.74 | 60.27 | 65.27 | 66.41 | 66.14 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，居行业前列，两项指标的行业排名分别为 10/73 ， 4/73。
[{"date":"2026-06-30","value":"39.27","vol":"31.09"},{"date":"2026-03-31","value":"32.08","vol":"291.45"},{"date":"2025-12-31","value":"58.87","vol":"39.10"},{"date":"2025-09-30","value":"33.04","vol":"44.93"},{"date":"2025-06-30","value":"-11.35","vol":"6771.91"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
39.27 | 32.08 | 58.87 | 33.04 | -11.35 |
| 行业(%) | 31.09 | 291.45 | 39.10 | 44.93 | 6771.91 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"173.80","vol":"18.81"},{"date":"2026-03-31","value":"134.34","vol":"71.92"},{"date":"2025-12-31","value":"124.32","vol":"36.03"},{"date":"2025-09-30","value":"93.33","vol":"44.79"},{"date":"2025-06-30","value":"-8.97","vol":"5.12"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
173.80 | 134.34 | 124.32 | 93.33 | -8.97 |
| 行业(%) | 18.81 | 71.92 | 36.03 | 44.79 | 5.12 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，两项指标的行业排名分别为 22/73 ， 12/73。
[{"date":"2026-06-30","value":"0.14","vol":"0.14"},{"date":"2026-03-31","value":"0.06","vol":"0.06"},{"date":"2025-12-31","value":"0.34","vol":"0.30"},{"date":"2025-09-30","value":"0.21","vol":"0.21"},{"date":"2025-06-30","value":"0.11","vol":"0.13"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.14 | 0.06 | 0.34 | 0.21 | 0.11 |
| 行业(次) | 0.14 | 0.06 | 0.30 | 0.21 | 0.13 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.69","vol":"0.63"},{"date":"2026-03-31","value":"0.27","vol":"0.28"},{"date":"2025-12-31","value":"1.71","vol":"1.26"},{"date":"2025-09-30","value":"0.88","vol":"0.88"},{"date":"2025-06-30","value":"0.56","vol":"0.54"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.69 | 0.27 | 1.71 | 0.88 | 0.56 |
| 行业(次) | 0.63 | 0.28 | 1.26 | 0.88 | 0.54 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，两项指标的行业排名分别为 35/73 ， 20/73。
[{"date":"2026-06-30","value":"0.46","vol":"-1291.20"},{"date":"2026-03-31","value":"41.69","vol":"-144.81"},{"date":"2025-12-31","value":"26.76","vol":"12.60"},{"date":"2025-09-30","value":"39.72","vol":"0.21"},{"date":"2025-06-30","value":"6.84","vol":"-1377.57"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 0.46 | 41.69 | 26.76 | 39.72 | 6.84 |
| 行业 | -1291.20 | -144.81 | 12.60 | 0.21 | -1377.57 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.81","vol":"1.53"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.79","vol":"1.73"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.62","vol":"1.53"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.81 | - | 0.79 | - | 0.62 |
| 行业 | 1.53 | 0.00 | 1.73 | 0.00 | 1.53 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 25/73 ， 19/73。
[{"date":"2026-06-30","value":"0.62","vol":"5.55"},{"date":"2026-03-31","value":"0.66","vol":"6.58"},{"date":"2025-12-31","value":"0.67","vol":"5.74"},{"date":"2025-09-30","value":"0.86","vol":"5.95"},{"date":"2025-06-30","value":"0.69","vol":"6.47"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
0.62 | 0.66 | 0.67 | 0.86 | 0.69 |
| 行业 | 5.55 | 6.58 | 5.74 | 5.95 | 6.47 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.33","vol":"4.13"},{"date":"2026-03-31","value":"0.42","vol":"5.09"},{"date":"2025-12-31","value":"0.45","vol":"4.39"},{"date":"2025-09-30","value":"0.44","vol":"4.79"},{"date":"2025-06-30","value":"0.25","vol":"5.16"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.33 | 0.42 | 0.45 | 0.44 | 0.25 |
| 行业 | 4.13 | 5.09 | 4.39 | 4.79 | 5.16 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：一般，低于行业平均，两项指标的行业排名分别为 4/73 ， 13/73。
[{"date":"2026-06-30","value":"47.02","vol":"30.05"},{"date":"2026-03-31","value":"48.55","vol":"29.49"},{"date":"2025-12-31","value":"49.07","vol":"29.33"},{"date":"2025-09-30","value":"49.32","vol":"27.48"},{"date":"2025-06-30","value":"48.49","vol":"27.37"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
47.02 | 48.55 | 49.07 | 49.32 | 48.49 |
| 行业(%) | 30.05 | 29.49 | 29.33 | 27.48 | 27.37 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.89","vol":"1.38"},{"date":"2026-03-31","value":"0.95","vol":"2.52"},{"date":"2025-12-31","value":"0.98","vol":"1.42"},{"date":"2025-09-30","value":"1.01","vol":"0.57"},{"date":"2025-06-30","value":"0.98","vol":"1.24"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.89 | 0.95 | 0.98 | 1.01 | 0.98 |
| 行业(%) | 1.38 | 2.52 | 1.42 | 0.57 | 1.24 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"0.09","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-0.51","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.78","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.19","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]